Download PDF
Zentralbl Chir 2003; 128(11): 900-905
DOI: 10.1055/s-2003-44796
Originalarbeiten und Übersichten

© Georg Thieme Verlag Stuttgart · New York

Chirurgische Therapie des hepatozellulären Karzinoms

Surgical Therapy of Hepatocellular CarcinomaA. Frilling1 , N. Frühauf1 , G. C. Sotiropoulos1 , V. Cicinnati1 , M. Malago1 , C. E. Broelsch1
  • 1Klinik für Allgemein- und Transplantationschirurgie, Universitätsklinikum Essen
Further Information

Publication History

Publication Date:
11 December 2003 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Das hepatozelluläre Karzinom ist das häufigste primäre Lebermalignom. In den meisten Fällen entwickelt sich der Tumor auf dem Boden einer Leberzirrhose. Als Tumormarker gilt das α-Fetoprotein. Bei bekannter Leberzirrhose sollen regelmäßige Screening-Untersuchungen unter Einschluss der Sonographie und der α-Fetoprotein-Bestimmung erfolgen. Chirurgische Therapie, entweder in Form von partieller Leberresektion oder Lebertransplantation, stellt die einzige Therapieoption mit der Möglichkeit eines Langzeitüberlebens dar. Bei Patienten mit einer Leberzirrhose beeinträchtigen die postoperative Leberinsuffizienz und hohe lokale Tumorrezidivraten die Ergebnisse der Resektion. Als geeignete Resektionskandidaten gelten Patienten ohne Leberzirrhose oder Zirrhosepatienten im Child-Pugh-Stadium A mit Tumoren kleiner als 5 cm. Für Patienten in höheren Zirrhosestadien mit Tumoren kleiner als 5 bis 7 cm bedeutet die Lebertransplantation die bessere therapeutische Option. Die Ergebnisse der Lebertransplantation werden durch die Wartezeit auf ein geeignetes Spenderorgan negativ beeinflusst. Die Lebendleberspende bietet eine neue Behandlungsmöglichkeit mit der Option der Verbesserung der Überlebensraten nach der Transplantation und der Erweiterung der Indikation zur Transplantation.

Abstract

Hepatocellular carcinoma (HCC) accounts for most primary malignancies of the liver. The most important risk factor is liver cirrhosis. HCC can be traced by the tumor marker α-fetoprotein. Patients with a known liver cirrhosis should regularly be screened, including sonography and α-fetoprotein evaluation. Surgical therapy - either partial liver resection or liver transplantation - is the only treatment that can potentially achieve long-term survival. The presence of liver cirrhosis is likely to induce postoperative liver insufficiency and is associated with higher local tumor recurrence rate. Patients without liver cirrhosis or Child-Pugh A patients with tumors smaller than 5 cm may be considered as the ideal target group for resection. For more advanced stages of cirrhosis and tumors of less than 5 cm up to 7 cm in size, liver transplantation offers a better prognosis. Long waiting time for a suitable organ negatively influences liver transplantation outcome. Living donor liver transplantation is a novel therapeutic option that improves posttransplant survival and extends the indication for transplantation in hepatocellular carcinoma.

Schlüsselwörter

Hepatozelluläres Karzinom - Leberzirrhose - Leberresektion - Lebertransplantation

Key words

Hepatocellular carcinoma - liver cirrhosis - liver resection - liver transplantation

Literatur

  • 1 Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M. et al . Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan.  Hepatology. 2002;  32 1224-1229
    PubMedGoogle Scholar
  • 2 Bosch F X, Ribes J, Borras J. Epidemiology of primary liver cancer.  Semin Liver Dis. 1999;  19 271-285
    PubMedGoogle Scholar
  • 3 Bruix J, Sherman M, Llovet M J, Beaugrand M, Lencioni R, Burroughs A K, Christensen E, Pagliaro L, Colombo M, Rodes J. for the EASL Panel of Experts on HCC . Clinical management of hepatocellular carcinoma. Conclusion of the Barcelona-2000 EASL conference.  J Hepatol. 2001;  35 421-430
    CrossrefPubMedGoogle Scholar
  • 4 Bruix J, Llovet J M. Prognostic prediction and treatment strategy in hepatocellular carcinoma.  Hepatology. 2002;  35 519-524
    CrossrefPubMedGoogle Scholar
  • 5 Busuttil R W, Farmer D G. The surgical treatment of primary hepatobiliary malignancy.  Liver Transpl Surg. 1996;  2 114-130
    PubMedGoogle Scholar
  • 6 Chevret S, Trinchet J C, Mathieu D, Rached A A, Beaugrand M, Chastang C. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma.  J Hepatol. 1999;  31 133-141
    CrossrefPubMedGoogle Scholar
  • 7 CLIPP . Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma.  Hepatology. 2000;  31 840-845
    CrossrefPubMedGoogle Scholar
  • 8 El-Serag H B. Hepatocellular carcinoma and hepatitis C in the United States.  Hepatology. 2002;  36 74-83
    CrossrefPubMedGoogle Scholar
  • 9 Fan S T, Ng I OL, Poon R TP. et al . Hepatectomy for hepatocellular carcinoma; the surgeon 's role in long-term survival.  Arch Surg. 1999;  134 1124-1130
    PubMedGoogle Scholar
  • 10 Farges O, Malassagne B, Flejou J F, Balzan S, Sauvanet A, Belghiti J. Risk of major liver resection in patients with underlying chronic liver disease. A reappraisal.  Ann Surg. 1999;  229 210-215
    CrossrefPubMedGoogle Scholar
  • 11 Fattovich G. Progression of hepatitis B and C to hepatocellular carcinoma in western countries.  Hepato-Gastroenterology. 1998;  45 1206-1213
    PubMedGoogle Scholar
  • 12 Figueras J, Ibanez L, Ramos E, Jaurrieta E, Ortiz- de-Urbina J, Pardo F. et al . Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study.  Liver Transpl. 2001;  7 877-883
    CrossrefPubMedGoogle Scholar
  • 13 Fong Y, Sun R L, Jarnagin W, Blumgart L H. An analysis of 412 cases of hepatocellular carcinoma at a Western center.  Ann Surg. 1999;  229 790-799
    CrossrefPubMedGoogle Scholar
  • 14 Freeman R B. Diagnosing hepatocellular carcinoma: a virtual reality.  Liver Transpl. 2002;  8 762-764
    CrossrefPubMedGoogle Scholar
  • 15 Fuster J, Garcia-Valdecasas J C, Grande L, Tabet J, Bruix J, Anglada T. et al . Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series.  Ann Surg. 1996;  223 297-302
    CrossrefPubMedGoogle Scholar
  • 16 Gebo K A, Chander G, Jenckes M W, Ghanem K G, Herlog F, Torbenson M S. et al . Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review.  Hepatology. 2002;  36 84-92
    CrossrefPubMedGoogle Scholar
  • 17 Grazi G L, Ercolani G, Pierangeli F, Del Gaudio M, Cescon M, Cavallari A, Mazziotti A. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value.  Ann Surg. 2001;  234 71-78
    CrossrefPubMedGoogle Scholar
  • 18 Hemming A W, Cattral M S, Reed A I, Van der Wert W J, Greig P D, Howard R J. Liver transplantation for hepatocellular carcinoma.  Ann Surg. 2001;  233 652-659
    CrossrefPubMedGoogle Scholar
  • 19 Iannitti D A, Dupuy D E, Mayo-Smith W W, Murphy B. Hepatic radiofrequency ablation.  Arch Surg. 2002;  137 422-427
    PubMedGoogle Scholar
  • 20 Iwatsuki S, Dvorchik I, Marsh J W, Madariaga J R, Carr B, Fung J J. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system.  J Am Coll Surg. 2000;  191 389-394
    CrossrefPubMedGoogle Scholar
  • 21 Izzo F, Cremona F, Ruffolo F, Palaia R, Parisi V, Curley S A. Outcome of 67 patients with hepatocellular cancer detected during screening of 1 125 patients with chronic hepatitis.  Ann Surg. 1998;  227 513-518
    CrossrefPubMedGoogle Scholar
  • 22 Jamagin W R, Gonen M, Fong Y, DeMatteo R P, Ben-Porat L, Little S. et al . Improvement in perioperative outcome after hepatic resection. Analysis of 1 803 consecutive cases over the past decade.  Ann Surg. 2002;  236 397-407
    CrossrefPubMedGoogle Scholar
  • 23 Kanematsu T, Furui J, Yanaga K, Okadaira S, Shimada M, Shirabe K. A 16-year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma: 1985-2000.  Surgery. 2002;  131 153-158
    CrossrefPubMedGoogle Scholar
  • 24 Kim T, Murakami T, Takahashi S, Tsuda K, Tomoda K, Narumi Y. et al . Optimal phases of dynamic CT for detecting hepatocellular carcinoma: evaluation of unenhanced and triple-phase images.  Abdom Imaging. 1999;  24 473-480
    CrossrefPubMedGoogle Scholar
  • 25 Libbrecht L, Bielen D, Verslype C, Vanbeckevoort D, Pirenne J, Nevens F, Desmet V. et al . Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pre-transplant imaging examination.  Liver Transpl. 2002;  8 749-761
    CrossrefPubMedGoogle Scholar
  • 26 Llovet J M, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification.  Semin Liver Dis. 1999;  19 329-338
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Llovet J M, Fuster J, Bruix. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.  Hepatology. 1999;  30 1434-1440
    CrossrefPubMedGoogle Scholar
  • 28 Llovet J M, Bruix J, Gores G J. Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy.  Hepatology. 2000;  31 1019-1021
    CrossrefPubMedGoogle Scholar
  • 29 Molmenti E P, Klintmalm G B. Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry.  Liver Transpl. 2002;  8 736-748
    CrossrefPubMedGoogle Scholar
  • 30 Olthoff K M, Millis J M, Rosove M H, Goldstein L I, Ramming K P, Busuttil R W. Is liver transplantation justified for the treatment of hepatic malignancies?.  Arch Surg. 1990;  125 1261-1266
    CrossrefPubMedGoogle Scholar
  • 31 Penn I. Hepatic transplantation for primary and metastatic cancers of the liver.  Surgery. 1991;  110 726-734
    PubMedGoogle Scholar
  • 32 Poon R TP, Fan S T, O’ Suilleabhain C B, Wong J. Aggressive management of patients with extrahepatic and intrahepatic recurrence of hepatocellular carcinoma by combined resection and locoregional therapy.  J Am Coll Surg. 2002;  195 311-318
    CrossrefPubMedGoogle Scholar
  • 33 Poon R TP, Fan S T, Wong J. Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter.  J Am Coll Surg. 2002;  194 592-602
    CrossrefPubMedGoogle Scholar
  • 34 Poon R TP, Fan S T, Tsang F HF, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.  Ann Surg. 2002;  235 466-486
    CrossrefPubMedGoogle Scholar
  • 35 Ringe B, Wittekind C, Bechstein W O, Bunzendahl H, Pichlmayr R. The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence.  Ann Surg. 1989;  209 88-98
    PubMedGoogle Scholar
  • 36 Roayaie S, Frischer J S, Emre S H, Fishbein T M, Sheiner P A, Sung M. et al . Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 cm.  Ann Surg. 2002;  235 533-539
    CrossrefPubMedGoogle Scholar
  • 37 Ruiz J, Mazzolini G, Sangro B, Qian C, Prieto J. Gene therapy of hepatocellular carcinoma.  Dig Dis. 2001;  19 324-332
    CrossrefPubMedGoogle Scholar
  • 38 Suehiro T, Terashi T, Shiotani S, Soejima Y, Sugimachi K. Liver transplantation for hepatocellular carcinoma.  Surgery. 2002;  131 190-194
    CrossrefPubMedGoogle Scholar
  • 39 Sugimachi K, Maehara S, Tanaka S, Shimada M, Sugimachi K. Repeat hepatectomy is the most useful treatment for recurrent hepatocellular carcinoma.  J Hepatobiliary Pancreat Surg. 2001;  8 410-416
    CrossrefPubMedGoogle Scholar
  • 40 Tanaka H, Hirohashi K, Kubo S, Shuto T, Higaki I, Kinoshita H. Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function.  Br J Surg. 2000;  87 879-882
    CrossrefPubMedGoogle Scholar
  • 41 Wayne J D, Lauwers G Y, Ikai I, Doherty D A, Belghiti J, Yamaoka Y. et al . Preoperative predictors of survival after resection of small hepatocellular carcinomas.  Ann Surg. 2002;  235 722-731
    CrossrefPubMedGoogle Scholar
  • 42 Yamamoto J, Okada S, Shimada K, Okusaka T, Yamasaki S, Ueno H. et al . Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection.  Hepatology. 2001;  34 707-713
    CrossrefPubMedGoogle Scholar
  • 43 Yao F Y, Ferrell L, Bass N M, Bacchetti P, Ascher N L, Roberts J P. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria.  Liver Transpl. 2002;  8 765-774
    CrossrefPubMedGoogle Scholar
  • 44 Yang H I, Lu S N, Liaw Y F, You S L, Sun C A, Wang L Y. et al . Hepatitis B e antigen and the risk of hepatocellular carcinoma.  N Engl J Med. 2002;  347 168-174
    PubMedGoogle Scholar
  • 45 Yokoyama I, Todo S, Iwatsuki S, Starzl T E. Liver transplantation in the treatment of primary liver cancer.  Hepatogastroenterology. 1990;  37 188-193
    PubMedGoogle Scholar

Prof. Dr. A. Frilling

Klinik für Allgemein- und Transplantationschirurgie

Universitätsklinikum Essen

Hufelandstr. 55

45122 Essen

Phone: 02 01/7 23 11 11

Fax: 02 01/7 23 59 46

Email: frilling@uni-essen.de